Skip to product information
$99.99
Retatrutide is an advanced GLP-3 receptor agonist specifically developed to enhance metabolic regulation. By simultaneously activating GLP-1, GLP-2, and glucagon receptors, it delivers a multifaceted approach to improving glycemic control, reducing appetite, and promoting weight loss. This targeted mechanism supports effective management of metabolic conditions, offering a promising option for patients seeking comprehensive therapeutic outcomes
Retatrutide targets and activates the receptors for three gut hormones:
- Glucagon-Like Peptide-1 (GLP-1): GLP-1 agonists slow down gastric emptying, increase the feeling of fullness, and lower blood sugar.
- Glucose-Dependent Insulinotropic Polypeptide (GIP): GIP also helps control blood sugar and has a positive effect on metabolism.
- Glucagon (GCG): Unlike GLP-1 and GIP, glucagon tends to increase blood sugar, but its effect in retatrutide is thought to increase energy expenditure, leading to a higher metabolism and more calories burned.
By targeting all three receptors simultaneously, retatrutide provides a powerful and comprehensive approach to managing weight and blood sugar.
Key Benefits
Weight Loss: Retatrutide has been demonstrated to induce significant and sustainable weight loss in individuals with obesity. In clinical trials, participants taking retatrutide lost an average of 10-15% of their body weight over 68 weeks.
Improved Glycemic Control: Retatrutide can improve blood sugar control in people with type 2 diabetes. It does this by stimulating the release of insulin and suppressing glucagon production.
Reduced Fat Mass: Unlike some other weight loss medications, retatrutide appears to specifically target fat mass, preserving muscle mass. This can lead to a more aesthetically pleasing and metabolically healthy weight loss.
Enhanced Insulin Sensitivity: Retatrutide can enhance insulin sensitivity, which can help prevent the development of type 2 diabetes or improve its management.
Reduced Cardiovascular Risk Factors: Studies have shown that retatrutide can reduce blood pressure, cholesterol levels, and other cardiovascular risk factors.
Convenience: Retatrutide is administered as a weekly injection, making it a convenient option for long-term weight management.
Safety: Overall, retatrutide appears to be well-tolerated, with the most common side effects being nausea, vomiting, and diarrhea. However, it is important to note that more long-term safety data is needed.
Other Potential Benefits:
Retatrutide may have potential benefits for treating non-alcoholic fatty liver disease (NAFLD).
It may also improve metabolic health in individuals with polycystic ovary syndrome (PCOS).
Disclaimer: This product is for research purposes only and is not intended for human consumption. By purchasing this product, the customer acknowledges and agrees to be a qualified researcher or professional who is using this product for strictly research, development, or educational purposes.
